Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume $0.09 0.00 (-0.65%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.09 +0.00 (+0.87%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Short Interest DataLyra Therapeutics (LYRA) has a short interest of 2.70 million shares. This marks a 21.62% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 1.88 million shares to cover all short positions.Current Short Interest2,700,000 sharesPrevious Short Interest2,220,000 sharesChange Vs. Previous Month+21.62%Dollar Volume Sold Short$320,760.00Short Interest Ratio1.5 Days to CoverLast Record DateApril 30, 2025Outstanding Shares66,267,000 sharesPercentage of Shares Shorted4.07%Today's Trading Volume979,788 sharesAverage Trading Volume1,882,077 sharesToday's Volume Vs. Average52% Short Selling Lyra Therapeutics? Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYRA Short Interest Over TimeLYRA Days to Cover Over TimeLYRA Percentage of Float Shorted Over Time Lyra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,700,000 shares $320,760.00 +21.6%N/A1.5 $0.12 4/15/20252,220,000 shares $204,684.00 -7.9%3.6%1.9 $0.09 3/31/20252,410,000 shares $304,383.00 +0.4%3.9%2.2 $0.13 3/15/20252,400,000 shares $412,800.00 +27.7%3.8%2 $0.17 2/28/20251,880,000 shares $402,320.00 -13.4%3.0%1.5 $0.21 2/15/20252,170,000 shares $451,794.00 +1.4%3.5%1.5 $0.21 1/31/20252,140,000 shares $391,192.00 +0.5%N/A1.2 $0.18 1/15/20252,130,000 shares $402,570.00 +1.4%N/A1.1 $0.19 12/31/20242,100,000 shares $433,440.00 +14.1%N/A1.1 $0.21 12/15/20241,840,000 shares $335,984.00 -16.4%N/A1.1 $0.18 Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20242,200,000 shares $455,400.00 -7.6%N/A1.4 $0.21 11/15/20242,380,000 shares $404,600.00 +16.7%N/A1.6 $0.17 10/31/20242,040,000 shares $560,796.00 -4.7%N/A2.1 $0.27 10/15/20242,140,000 shares $488,776.00 -24.9%N/A2.2 $0.23 9/30/20242,850,000 shares $732,450.00 -9.2%N/A3.2 $0.26 9/15/20243,140,000 shares $879,200.00 +6.1%N/A2.7 $0.28 8/31/20242,960,000 shares $952,232.00 -28.7%N/A2.3 $0.32 8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29 7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33 7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31 6/30/20241,990,000 shares $550,633.00 +28.4%N/A0.5 $0.28 6/15/20241,550,000 shares $457,560.00 +71.8%N/A0.4 $0.30 5/31/2024902,200 shares $295,921.60 +49.6%N/A0.3 $0.33 5/15/2024603,000 shares $214,547.40 +45.7%N/A0.2 $0.36 4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16 4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27 3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22 3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93 2/29/2024160,200 shares $842,652.00 -13.6%N/A0.6 $5.26 2/15/2024185,400 shares $927,000.00 +43.5%N/A0.8 $5.00 1/31/2024129,200 shares $587,860.00 -5.6%N/A0.6 $4.55 1/15/2024136,900 shares $736,522.00 -22.6%N/A0.6 $5.38 12/31/2023176,800 shares $926,432.00 +2.4%N/A0.9 $5.24 12/15/2023172,600 shares $802,590.00 -24.4%N/A0.7 $4.65 11/30/2023228,300 shares $755,673.00 -13.9%N/A0.6 $3.31 11/15/2023265,200 shares $766,428.00 -17.3%N/A0.7 $2.89 10/31/2023320,600 shares $952,182.00 +43.2%N/A0.9 $2.97 10/15/2023223,900 shares $801,562.00 -38.2%N/A0.6 $3.58 9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91 9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 8/31/202355,300 shares $192,444.00 -19.5%N/A0.3 $3.48 8/15/202368,700 shares $245,946.00 -67.0%N/A0.4 $3.58 7/31/2023208,100 shares $670,082.00 -62.3%N/A1.1 $3.22 7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06 6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11 6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99 5/31/2023285,500 shares $733,735.00 +1,513.0%N/A3.7 $2.57 5/15/202317,700 shares $46,197.00 -31.4%N/A0.5 $2.61 4/30/202325,800 shares $61,920.00 +27.1%N/A0.7 $2.40 4/15/202320,300 shares $48,517.00 +178.1%N/A0.6 $2.39 3/31/20237,300 shares $14,673.00 -29.1%N/A0.2 $2.01 3/15/202310,300 shares $21,012.00 -32.2%N/A0.3 $2.04 2/28/202315,200 shares $36,176.00 +22.6%N/A0.5 $2.38 2/15/202312,400 shares $30,256.00 +21.6%N/A0.4 $2.44 1/31/202310,200 shares $29,070.00 -21.5%N/A0.3 $2.85 1/15/202313,000 shares $36,010.00 -29.7%N/A0.2 $2.77 12/30/202218,500 shares $58,090.00 +44.5%N/A0.3 $3.14 12/15/202212,800 shares $34,944.00 -41.6%N/A0.2 $2.73 11/30/202221,900 shares $76,869.00 +0.5%N/A0.3 $3.51 11/15/202221,800 shares $85,020.00 No ChangeN/A0.3 $3.90 10/31/202221,800 shares $102,242.00 -27.6%N/A0.3 $4.69 10/15/202230,100 shares $144,480.00 -16.4%N/A0.9 $4.80 9/30/202236,000 shares $180,360.00 -45.4%N/A1 $5.01 9/15/202265,900 shares $392,764.00 -25.5%N/A1.6 $5.96 8/31/202288,400 shares $511,836.00 -18.8%N/A1.4 $5.79 8/15/2022108,800 shares $683,264.00 -22.6%N/A1.6 $6.28 7/31/2022140,600 shares $912,494.00 -44.2%N/A1.9 $6.49 7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69 6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65 6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02 5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35 5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88 4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65 4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51 3/31/202277,200 shares $310,344.00 +19.0%0.9%0.5 $4.02 3/15/202264,900 shares $262,845.00 -44.8%0.7%1.5 $4.05 2/28/2022117,500 shares $572,225.00 +36.3%1.2%2.4 $4.87 2/15/202286,200 shares $387,900.00 +9.1%0.9%1.6 $4.50 1/31/202279,000 shares $323,110.00 +5.6%0.8%1.3 $4.09 1/15/202274,800 shares $295,460.00 +4.0%0.8%1.2 $3.95 12/31/202171,900 shares $313,484.00 -5.8%0.8%1.2 $4.36 12/15/202176,300 shares $334,194.00 -1.0%0.8%1.4 $4.38 11/30/202177,100 shares $431,760.00 +2.5%0.8%1.4 $5.60 11/15/202175,200 shares $539,936.00 -51.4%0.9%1.5 $7.18 10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30 10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85 9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12 9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28 8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14 8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44 7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45 6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03 6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17 5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18 5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46 4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18 4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89 3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17 3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98 2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00 2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19 1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68 1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96 LYRA Short Interest - Frequently Asked Questions What is Lyra Therapeutics' current short interest? Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,700,000 shares of LYRA short. Learn More on Lyra Therapeutics' current short interest. What is a good short interest ratio for Lyra Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYRA shares currently have a short interest ratio of 2.0. Learn More on Lyra Therapeutics's short interest ratio. Is Lyra Therapeutics' short interest increasing or decreasing? Lyra Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,700,000 shares, an increase of 21.6% from the previous total of 2,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lyra Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: Femasys Inc. (4.05%), Allurion Technologies Inc. (2.23%), Nephros, Inc. (0.09%), QT Imaging Holdings, Inc. (1.89%), CollPlant Biotechnologies Ltd. (0.02%), NEXGEL, Inc. (1.18%), IRIDEX Co. (2.18%), Nexalin Technology, Inc. (1.11%), Beyond Air, Inc. (3.11%), ReWalk Robotics Ltd. (4.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Lyra Therapeutics stock? Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyra Therapeutics? A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further. How often is Lyra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Femasys Short Interest Data Allurion Technologies Short Interest Data Nephros Short Interest Data QT Imaging Short Interest Data CollPlant Biotechnologies Short Interest Data NEXGEL Short Interest Data IRIDEX Short Interest Data Nexalin Technology Short Interest Data Beyond Air Short Interest Data ReWalk Robotics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYRA) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
